PF-Atlas › Clinical Trials › NCT07583589
Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis
Nintedanib,Dextromethorphan · Phase 2
Registry ID
NCT07583589
Phase
Phase 2
Status
Not yet recruiting
Drug / intervention
Nintedanib,Dextromethorphan
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Start
2026-05-12
Enrollment
60
About this trial
Nintedanib combined with or without Dextromethorphan for the treatment of IPF, with FVC as the primary efficacy endpoint to evaluate its effectivenes.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT07583589 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.